d NF-B transcription factors are central regulators of inflammation and when dysregulated contribute to malignant transformation. IB kinase (IKK; IKKi, encoded by IKBKE) is a breast oncogene that is amplified in 30% of breast cancers and drives transformation in an NF-B-dependent manner. Here we demonstrate that IKK interacts with and phosphorylates tumor necrosis factor receptor-associated factor 2 (TRAF2) at Ser11 in vitro and in vivo. This activity promotes Lys63-linked TRAF2 ubiquitination and NF-B activation and is essential for IKK transformation. Breast cancer cells that depend on IKK expression for survival are also dependent on TRAF2. This work defines TRAF2 phosphorylation to be one key effector of IKK-induced mammary epithelial cell transformation. N F-B activation plays an important role in innate immunity and inflammation. Several lines of evidence indicate that dysregulation of NF-B signaling also contributes to malignant transformation through both cell autonomous and cell nonautonomous mechanisms. Although cancers associated with chronic inflammation are frequently dependent on aberrant NF-B activity induced by the tumor microenvironment (11,16,17,25), somatic mutations in components of the NF-B pathway that lead to constitutive NF-B activation also contribute directly to tumorigenicity (5,8,18,20,23).Activation of the canonical NF-B pathway is facilitated by the recruitment of receptor-associated adaptor molecules such as tumor necrosis factor (TNF) receptor-associated factors (TRAFs) (24). TRAF proteins mediate the formation of protein complexes that activate the classical IB kinase (IKK) complex, consisting of the catalytic kinases IKK␣ and IKK and the regulatory subunit IKK␥/NEMO. IKK complex activation triggers proteasome-mediated degradation of the key inhibitory molecule IB␣ that, in turn, permits nuclear translocation of NF-B dimers. In addition to this canonical mode of activation in response to TNF, an array of inflammatory stimuli activates several signaling pathways that converge to activate NF-B (10).IB kinase ε (IKKε; encoded by IKBKE) is a noncanonical IKK family member that activates both interferon and NF-B signaling. In response to viruses, both IKKε and another noncanonical IKK, TBK1, form a complex to phosphorylate interferon regulatory factor 3 (IRF3) and IRF7 (6). This activity is essential for the nuclear translocation of IRF3 and IRF7 and transcriptional activation of type I interferon genes (9). In addition to its role in innate immunity, IKKε is also a breast oncogene that is amplified and overexpressed in up to 30% of breast cancers (4). Suppression of IKKε induces apoptosis in breast cancer cell lines that harbor increased IKKε copy number. IKKε overexpression induces malignant transformation in immortalized human and murine cells in an NF-B-dependent manner (4).We recently employed a scanning peptide library screen and Scansite bioinformatic analysis to identify an IKKε recognition motif and potential IKKε substrates. Using this combined proteomic and bioinformatic a...